View Older Stories View More Recent Stories
-
Inspire Medical Systems (INSP) PT Lowered to $160 at Jefferies
-
Inspire Medical Systems (INSP) PT Lowered to $170 at Mizuho
-
Inspire Medical Systems (INSP) PT Lowered to $116 at Leerink Partners
-
Truist Securities Downgrades Inspire Medical Systems (INSP) to Hold
-
Inspire Medical Systems (INSP) PT Lowered to $140 at Stifel
-
KeyBanc Downgrades Inspire Medical Systems (INSP) to Sector Weight
-
Inspire Medical Systems (INSP) Tops Q2 EPS by 24c ; Offers Guidance
-
JPMorgan Downgrades Inspire Medical Systems (INSP) to Neutral
-
Apple (AAPL) announces hearing aid features, sleep apnea notifications for products
-
KeyBanc Reiterates Overweight Rating on Inspire Medical Systems (INSP)
-
Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names
-
Stifel Reiterates Hold Rating on Inspire Medical Systems (INSP)
-
RBC Capital on Inspire Medical Systems (INSP): 'Strong Start to 2025 With Inspire V Launch Potential'
-
KeyBanc on Inspire Medical Systems (INSP): 'All About Inspire V'
-
Inspire Medical Systems (INSP) Tops Q1 EPS by 34c, provides guidance
-
Inspire Medical Systems (INSP) Appoints Paul T. Hoff and Ruchir P. Patel as Vice President, Senior Medical Directors
-
Inspire Medical Systems (INSP) PT Lowered to $175 at Stifel
-
Inspire Medical Systems (INSP) PT Lowered at RBC Capital; 'The Stock is Undervalued'
-
RBC Capital Assesses U.S. Tariff Impact Across Industries
-
INSPIRE MEDICAL STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Inspire Medical Systems, Inc. (INSP) and Encourages Long-Term INSP Investors to Contact the Firm
-
RBC Capital: 'Opportunities Across MedTech Stocks'
-
Piper Sandler: 'Inspire Medical Systems (INSP) Showed Well and Better Than We Expected'
-
UBS Reiterates Buy Rating on Inspire Medical Systems (INSP)
-
UBS Reiterates Buy Rating on Inspire Medical Systems (INSP)
-
RBC on Inspire Medical Systems (INSP): 'Solid Q4 EPS Beat; Profitability Metrics Continue to Outperform'
-
Inspire Medical Systems (INSP) PT Lowered at Truist as 'Solid 4Q May Get Overshadowed by DOJ CID'
-
Inspire Medical Systems (INSP) PT Lowered to $220 at Morgan Stanley
-
Piper Sandler Reiterates Overweight on Inspire Medical Systems (INSP) as 'P&L Leverage Shines Again'
-
Inspire Medical Systems (INSP) PT Raised to $194 at Leerink Partners
-
Inspire Medical Systems (INSP) Tops Q4 EPS by 43c, provides guidance
-
Inspire Medical Systems (INSP) PT Lowered to $233 at Piper Sandler Following KOL Checks
-
Inspire Medical Systems (INSP) PT Lowered to $234 at KeyBanc
-
MedTech sector outlook for 2025: Truist Securities
-
Inspire Medical Systems (INSP) PT Lowered to $190 at Stifel, Citing 'Limited Future Revenue Upside'
-
Piper Sandler on Inspire Medical Systems (INSP): 'Recent Stock Move Presents Buying Opportunity'
-
Inspire Medical Systems (INSP) Reports Prelim Q4
-
Piper Sandler on HGNS Devices Following Eli Lilly's Zepbound FDA Indication Approval
-
Medical Technology and Devices: Piper Sandler Shares 'Quick Thoughts on HC Conference in Jan'
-
RBC's Best Picks For 2025 in Medical Supplies & Devices: 'Oasis of Opportunity Awaits as MedTech Momentum Continues'
-
Inspire Medical Systems (INSP) Announces $75M Accelerated Share Buyback
-
Inspire Medical Systems (INSP) PT Raised to $250 at Truist Securities
-
Inspire Medical Systems (INSP) PT Raised to $260 at Piper Sandler
-
Inspire Medical Systems (INSP) PT Raised to $252 at Baird
-
Inspire Medical Systems (INSP) Tops Q3 EPS by 54c, increases guidance
-
Inspire Medical Systems (INSP) PT Raised to $240 at Baird
-
Inspire Medical Systems (INSP) PT Raised to $240 at Truist Securities
-
Lake Street Capital Markets Reiterates Buy Rating on Inspire Medical Systems (INSP)
-
Zurn Elkay Water, Clear Secure, TG Therapeutics, others to join S&P SmallCap 600
-
Inspire Medical Systems (INSP) adds 10% on CEO comments
-
Inspire Medical Systems (INSP) Announces Extension of Private Placement and Closing of First Tranche
